≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Direct fill therapy

PheWeb

OPER_SFA

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Operations: NOMESCO codes ^SFA

3368

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

3368

diagram downward connector

Check minimum number of events None

3368

diagram downward connector

Include endpoints None

3368

diagram downward connector
OPER_SFA

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 3368 1781 1587
Unadjusted prevalence (%) 0.95 0.90 1.01
Mean age at first event (years) 48.52 46.62 50.66

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.08 5.05 [2.70, 9.44] 3.9e-7 306
15 years 0.01 1.54 [0.85, 2.79] 1.5e-1 75
5 years 0.01 7.93 [5.10, 12.33] 3.9e-20 141
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: OPER_SFA – Direct fill therapy
GWS hits:

Survival analyses between endpoints

↥

Plot

before Direct fill therapy
after Direct fill therapy

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Direct fill therapy

↥